Recombinant multi-species COL6A3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine COL6A3 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes the alpha-3 chain, one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The alpha-3 chain of type VI collagen is much larger than the alpha-1 and -2 chains. This difference in size is largely due to an increase in the number of subdomains, similar to von Willebrand Factor type A domains, that are found in the amino terminal globular domain of all the alpha chains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in the type VI collagen genes are associated with Bethlem myopathy, a rare autosomal dominant proximal myopathy with early childhood onset. Mutations in this gene are also a cause of Ullrich congenital muscular dystrophy, also referred to as Ullrich scleroatonic muscular dystrophy, an autosomal recessive congenital myopathy that is more severe than Bethlem myopathy. Multiple transcript variants have been identified, but the full-length nature of only some of these variants has been described. [provided by RefSeq, Jun 2009]
The Alternative Names of target: BTHLM1,BTHLM1C,COL6A3,Col6a-3,Col6a3,Collagen alpha-3(VI) chain,DYT27,UCMD1,UCMD1C
Go
to COL6A3 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-T83450-Ag-1/ GM-Tg-hg-T83450-Ag-2 | Human COL6A3 protein | Human |
| GM-Tg-rg-T83450-Ag-1/ GM-Tg-rg-T83450-Ag-2 | Rat COL6A3 protein | Rat |
| GM-Tg-mg-T83450-Ag-1/ GM-Tg-mg-T83450-Ag-2 | Mouse COL6A3 protein | Mouse |
| GM-Tg-cynog-T83450-Ag-1/ GM-Tg-cynog-T83450-Ag-2 | Cynomolgus/Rhesus macaque COL6A3 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-T83450-Ag-1/ GM-Tg-felg-T83450-Ag-2 | Feline COL6A3 protein | Feline |
| GM-Tg-cang-T83450-Ag-1/ GM-Tg-cang-T83450-Ag-2 | Canine COL6A3 protein | Canine |
| GM-Tg-bovg-T83450-Ag-1/ GM-Tg-bovg-T83450-Ag-2 | Bovine COL6A3 protein | Bovine |
| GM-Tg-equg-T83450-Ag-1/ GM-Tg-equg-T83450-Ag-2 | Equine COL6A3 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-T83450-Ag-1/ GM-Tg-hg-T83450-Ag-2;
GM-Tg-rg-T83450-Ag-1/ GM-Tg-rg-T83450-Ag-2;
GM-Tg-mg-T83450-Ag-1/ GM-Tg-mg-T83450-Ag-2; GM-Tg-cynog-T83450-Ag-1/ GM-Tg-cynog-T83450-Ag-2; GM-Tg-felg-T83450-Ag-1/ GM-Tg-felg-T83450-Ag-2; GM-Tg-cang-T83450-Ag-1/ GM-Tg-cang-T83450-Ag-2; GM-Tg-bovg-T83450-Ag-1/ GM-Tg-bovg-T83450-Ag-2; GM-Tg-equg-T83450-Ag-1/ GM-Tg-equg-T83450-Ag-2 |
| Products Name | COL6A3 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | COL6A3 |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine COL6A3 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.